Cellceutix “Developing A Still-Secret Prodrug For Psoriasis” and a “Heralded Cancer Candidate” Reported By Elsevier Business Intelligence
October 26, 2012 | In the News
Cellceutix CEO, and Advisor Jim Boeheim Interviewed by Boston Herald About New Cancer Drug; Company Provides Update on p53 Compounds From Annual ASCO Meeting
June 4, 2012 | In the News,Press Releases